Journal•ISSN: 0828-282X
Canadian Journal of Cardiology
Elsevier BV
About: Canadian Journal of Cardiology is an academic journal published by Elsevier BV. The journal publishes majorly in the area(s): Medicine & Myocardial infarction. It has an ISSN identifier of 0828-282X. Over the lifetime, 8022 publications have been published receiving 138056 citations. The journal is also known as: Journal canadien de cardiologie & Journal canadienne de cardiologie.
Papers published on a yearly basis
Papers
More filters
Journal Article•
TL;DR: Elliott M. Antman,MD, FACC, FAHA, Chair; Daniel T. Anbe, MD, F ACC,FAHA; Paul Wayne Armstrong, MD; Eric R. Bates; Lee A. Green; Mary Hand; Judith S. Kushner; and Sidney C. Sloan.
7,134 citations
University of Calgary1, Montreal Heart Institute2, University of Alberta3, Laval University4, University of British Columbia5, McGill University Health Centre6, McGill University7, University of Toronto8, McMaster University9, Robarts Research Institute10, Population Health Research Institute11, University of Ottawa12, Alberta Health Services13
TL;DR: Risk assessment and lipid determination should be considered in individuals older than 40 years of age or in those at increased risk regardless of age, and recommendation for the use of nonstatin medications is provided.
805 citations
McGill University Health Centre1, University of Ottawa2, St. Paul's Hospital3, Libin Cardiovascular Institute of Alberta4, Centre Hospitalier Universitaire de Sherbrooke5, McMaster University6, Robarts Research Institute7, University of Calgary8, University of Toronto9, Population Health Research Institute10, University of British Columbia11, University of Alberta12, McGill University13
TL;DR: The present article represents the 2009 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult.
786 citations
TL;DR: Diabetes and hypertension as comorbidities are discussed and some vascular mechanisms that predispose to both conditions are highlighted, focusing on advanced glycation end products, oxidative stress, inflammation, the immune system, and microRNAs.
771 citations
Libin Cardiovascular Institute of Alberta1, Montreal Heart Institute2, Robarts Research Institute3, University of British Columbia4, University of Ottawa5, Laval University6, McGill University7, Centre Hospitalier Universitaire de Sherbrooke8, McMaster University9, University of Calgary10, University of Toronto11, Population Health Research Institute12, University of Alberta13, Halifax14
TL;DR: An updated version of the CCS Dyslipidemia guidelines is presented, incorporating new recommendations based on recent findings and harmonizing CCS guidelines with those from other Societies, to increase the appropriate use of evidence-based cardiovascular disease event risk assessment in the management of dys Lipidemia.
754 citations